Ariad Pharmaceuticals Inc $5.81

down -0.09


22/8/2014 10:21 AM  |  NASDAQ : ARIA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ARIA Trend Analysis - it has underperformed the S&P 500 by 85%

Partner Headlines

  1. ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel

    Benzinga
  2. Morning Market Movers

    Benzinga
  3. Benzinga's Top #PreMarket Gainers

    Benzinga
  4. Benzinga's M&A Chatter for Wednesday July 23, 2014

    Benzinga
  5. ARIAD Announces Continuation of Iclusig Review Related to Article 20 Procedure ...

    Benzinga
  6. 3 Biotech Stocks Backed By Big Money

    Benzinga
  7. Morning Market Losers

    Benzinga
  8. Benzinga's Top #PreMarket Losers

    Benzinga
  9. Earnings Scheduled For May 7, 2014

    Benzinga
  10. Morning Market Movers

    Benzinga
  11. Benzinga's Top #PreMarket Gainers

    Benzinga
  12. Market Wrap For March 28: Markets Still Positive Despite Giving Up Early ...

    Benzinga
  13. Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte ...

    Benzinga
  14. Mid-Morning Market Update: Markets Open Higher; BlackBerry Reports Smaller-Than-Expected ...

    Benzinga
  15. Benzinga's Top #PreMarket Gainers

    Benzinga
  16. Morning Market Movers

    Benzinga
  17. Top Trending Tickers On StockTwits For March 14

    Benzinga
  18. Benzinga's Top Downgrades

    Benzinga
  19. Market Wrap For February 25: Markets End The Day Relatively Flat

    Benzinga
  20. Top Trending Tickers On StockTwits For February 25

    Benzinga
  21. Earnings Scheduled For February 25, 2014

    Benzinga
  22. You Can No Longer Ignore Biotech

    GuruFocus
  23. Credit Suisse Reports Ariad's Iclusig is 'Essential Drug'

    Benzinga
  24. Tug Of War In Ariad Pharmaceuticals

    Benzinga
  25. Benzinga's M&A Chatter for Monday January 27, 2014

    Benzinga
  26. Top Trending Tickers On StockTwits For January 27

    Benzinga
  27. Market Wrap For January 24: Fear Is Back In The Markets

    Benzinga
  28. Ariad Shares Continue to Surge Amidst Buyout Rumors

    Benzinga
  29. Ariad Pharnaceuticals Continues To Rally

    Benzinga
  30. Mid-Afternoon Market Update: Markets Get Hammered on China Fears as Microsoft ...

    Benzinga
  31. Top Trending Tickers On StockTwits For January 23

    Benzinga
  32. Benzinga's Top #PreMarket Gainers

    Benzinga
  33. Benzinga's M&A Chatter for Wednesday January 22, 2014

    Benzinga
  34. Market Wrap For January 17: Stocks Finish Week With Mixed Results

    Benzinga
  35. Top Trending Tickers On StockTwits For January 17

    Benzinga
  36. Benzinga's Top #PreMarket Gainers

    Benzinga
  37. Benzinga's Top #PreMarket Losers

    Benzinga
  38. UPDATE: JMP Securities Reiterates Coverage on ARIAD Pharmaceuticals, Sees ...

    Benzinga
  39. Market Wrap For January 6: Busy Day For Analysts Upgrades and Downgrades

    Benzinga
  40. UPDATE: Ariad Pharmaceuticals Downgraded by Citigroup

    Benzinga
  41. Benzinga's Top #PreMarket Losers

    Benzinga
  42. Benzinga's Top Downgrades

    Benzinga
  43. Market Wrap For January 2: Markets Begin 2014 on Negative Note

    Benzinga
  44. Mid-Afternoon Market Update: Markets Look to Close Red as Solar Stocks ...

    Benzinga
  45. Mid-Day Market Update: ANN Surges On Analyst Upgrade; DryShips Shares Decline

    Benzinga
  46. Mid-Morning Market Update: Markets Tumble; Fiat To Acquire Rest Of Chrysler

    Benzinga
  47. Benzinga's Top #PreMarket Gainers

    Benzinga
  48. ARIAD to Present at JP Morgan Healthcare Conference on Tuesday, January ...

    Benzinga
  49. Mid-Day Market Update: US Markets Turn Lower; Twitter Shares Fall On Analyst ...

    Benzinga
  50. Mid-Morning Market Update: Markets Mostly Higher; Textron To Acquire Beechcraft ...

    Benzinga
Trading Center